What do systematic reviews say?

Intervention not reported

The intervention showed no clear difference in relapses/death (instead of disease‐free survival）[2] (low certainty).

• Interleukin‐2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission 2015 · Cochrane Headline outcomes only
  HR 0.95 [0.86, 1.06]
  6 studies · 1426 participants
  Low